0001237899-12-000030.txt : 20120223
0001237899-12-000030.hdr.sgml : 20120223
20120223114615
ACCESSION NUMBER: 0001237899-12-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120221
FILED AS OF DATE: 20120223
DATE AS OF CHANGE: 20120223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powchik Peter
CENTRAL INDEX KEY: 0001377247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 12632683
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0304
4
2012-02-21
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001377247
Powchik Peter
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Clinical Development & Reg
Common Stock
2012-02-21
4
M
0
49428
15.64
A
64572
D
Common Stock
2012-02-21
4
F
0
7705
100.32
D
56867
D
Common Stock
2012-02-21
4
F
0
18530
100.32
D
38337
D
Common Stock
2012-02-21
4
M
0
20000
20.32
A
58337
D
Common Stock
2012-02-21
4
F
0
4050
100.32
D
54287
D
Common Stock
2012-02-21
4
F
0
7347
100.32
D
46940
D
Common Stock
2012-02-21
4
M
0
25438
21.92
A
72378
D
Common Stock
2012-02-21
4
F
0
5558
100.32
D
66820
D
Common Stock
2012-02-21
4
F
0
9158
100.32
D
57662
D
Common Stock
2012-02-21
4
M
0
15000
16.8
A
72662
D
Common Stock
2012-02-21
4
F
0
2511
100.32
D
70151
D
Common Stock
2012-02-21
4
F
0
5753
100.32
D
64398
D
Common Stock
2012-02-22
4
S
0
4200
94.71
D
60198
D
Common Stock
2012-02-22
4
S
0
10800
95.46
D
49398
D
Common Stock
2012-02-22
4
S
0
23454
96.45
D
25944
D
Common Stock
2012-02-22
4
S
0
9600
97.58
D
16344
D
Common Stock
2012-02-22
4
S
0
1200
98.05
D
15144
D
Common Stock
1532
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
15.64
2012-02-21
4
M
0
49428
D
2016-10-02
Common Stock
49428
0
D
Non-Qualified Stock Option (right to buy)
16.8
2012-02-21
4
M
0
15000
D
2018-12-17
Common Stock
15000
30000
D
Non-Qualified Stock Option (right to buy)
20.32
2012-02-21
4
M
0
20000
D
2016-12-18
Common Stock
20000
0
D
Non-Qualified Stock Option (right to buy)
21.92
2012-02-21
4
M
0
25438
D
2017-12-17
Common Stock
25438
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 4,200 shares of Company stock on February 22, 2012 at prices ranging from $94.22 to $94.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price.
Represents volume-weighted average price of sales of 10,800 shares of Company stock on February 22, 2012 at prices ranging from $95.00 to $95.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price.
Represents volume-weighted average price of sales of 23,454 shares of Company stock on February 22, 2012 at prices ranging from $96.00 to $96.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price.
Represents volume-weighted average price of sales of 9,600 shares of Company stock on February 22, 2012 at prices ranging from $97.00 to $97.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price.
Represents volume-weighted average price of sales of 1,200 shares of Company stock on February 22, 2012 at prices ranging from $98.01 to $98.27. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 22, 2012 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Peter Powchik
2012-02-23